Biological SamplesPATH-AIRCHUNCT05887089
Analytical Impact of the Transport of Pathological Biological Material by Drone
An observational study of Biological Samples, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.
Trial summary
The Hospital Group of Territory Somme Littoral Sud, through its biology sector and in partnership with the company DELIVRONE, aims to engage in the experiment of transporting biological samples by means of a drone platform. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Biological Samples
- What is being tested?
- drone transport
- How many people
- 0 participants
- Where
- 1 siteFrance
- Study dates
- 22 May 2023to Sep 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: If eligible for the study, patients from the central blood collection unit and the day hospitals of the CHU Amiens-Picardie will be offered to participate in the study. After information and consent of the patient, blood sampling will be performed to obtain the samples necessary for the normal medical management of the patient, as well as additional tubes corresponding to the same prescribed analyses. The collection of the extra tubes will therefore be done at the same time as the routine collection, without any additional invasive procedure.
Who may be able to join
- Patients admitted to the Amiens-Picardie University Hospital and having benefited from medical biology examinations including the parameters of interest
- according to the usual management modalities and without additional sampling
- at the time of the test period
Who cannot join
- Refusal to participate in the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Verification of the Absence of Analytical Impact of the Transport of Pathological Biological Material by Drone Within the Amiens-Picardie University Hospital
The Hospital Group of Territory Somme Littoral Sud, through its biology sector and in partnership with the company DELIVRONE, aims to engage in the experiment of transporting biological samples by means of a drone platform. Transport by air will be between the CHAM, the Abbeville Hospital and the CHU Amiens-Picardie by flying as much as possible over the waterways via the Somme. With a flight speed of around 100km/h at an altitude between 80 and 120 m, drones will be able to connect sites in less than an hour by transporting packages between 2 and 3 kg. Powered by propellers connected to rechargeable batteries, these drones do not emit CO2. This type of transport has not been validated in France by measuring the analytical impact of transport constraints for medical biology, and has never been evaluated according to the criteria of ISO 15189 standard allowing the certification of medical biology laboratories. Validation steps of this transportation method are therefore necessary on pathological samples prior to routine use. The aim of the project is to verify the absence of analytical impact of the transport of pathological biological samples by drone under defined flight conditions, according to the ISO15189 norm.
- Conditions
- Biological Samples
- Being tested
- drone transport
- Keywords
- drone transport, biological samples, unmanned aerial system, UAS
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
drone transportOther
additional transport of samples at room temperature by drone (departure from the CHU Amiens-Picardie, 1 hour flight in the CHU Amiens-Picardie air perimeter, return to the CHU Amiens-Picardie)
| Study group | Role | What they receive |
|---|---|---|
| no intervention | Not described | |
| drone transportation | Not described Receives: Other: drone transport |
What is being measured
The primary outcome is the main question the study is designed to answer.
variation of ASAT concentration between both groups
Measured: one day
variation of ALAT concentration between both groups
Measured: one day
variation of BNP concentration between both groups
Measured: one day
variation of LDH concentration between both groups
Measured: one day
variation of Glucose concentration between both groups
Measured: one day
variation of Troponin concentration between both groups
Measured: one day
variation of Potassium concentration between both groups
Measured: one day
variation of HIL concentration between both groups
Measured: one day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jun 2023
- Study start22 May 2023
- Primary completionSep 2023 (estimated)
- Study completionSep 2023 (estimated)
Why it stopped: no participants enrolled
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Biological SamplesStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire, AmiensThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05887089
- Sponsor's protocol ID
- PI2023_843_0030
- Acronym
- PATH-AIRCHU
- Status last verified
- Sep 2025
- First submitted
- 24 May 2023
- Last updated
- 6 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Verification of the Absence of Analytical Impact of the Transport of Pathological Biological Material by Drone Within the Amiens-Picardie University Hospital
- ClinicalTrials.gov ID
- NCT05887089
- Acronym / sponsor ID
- PATH-AIRCHU / PI2023_843_0030
- Conditions
- Biological Samples
- Keywords
- drone transport, biological samples, unmanned aerial system, UAS
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: no participants enrolled
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire, AmiensUniversity, hospital or other
- Study start
- 22 May 2023 (actual)
- Primary completion
- Sep 2023 (estimated)
- Study completion
- Sep 2023 (estimated)
- First posted
- 2 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Hospital Group of Territory Somme Littoral Sud, through its biology sector and in partnership with the company DELIVRONE, aims to engage in the experiment of transporting biological samples by means of a drone platform. Transport by air will be between the CHAM, the Abbeville Hospital and the CHU Amiens-Picardie by flying as much as possible over the waterways via the Somme. With a flight speed of around 100km/h at an altitude between 80 and 120 m, drones will be able to connect sites in less than an hour by transporting packages between 2 and 3 kg. Powered by propellers connected to rechargeable batteries, these drones do not emit CO2. This type of transport has not been validated in France by measuring the analytical impact of transport constraints for medical biology, and has never been evaluated according to the criteria of ISO 15189 standard allowing the certification of medical biology laboratories. Validation steps of this transportation method are therefore necessary on pathological samples prior to routine use. The aim of the project is to verify the absence of analytical impact of the transport of pathological biological samples by drone under defined flight conditions, according to the ISO15189 norm.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| no intervention | – | – |
| drone transportation | – | Other: drone transport |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- If eligible for the study, patients from the central blood collection unit and the day hospitals of the CHU Amiens-Picardie will be offered to participate in the study. After information and consent of the patient, blood sampling will be performed to obtain the samples necessary for the normal medical management of the patient, as well as additional tubes corresponding to the same prescribed analyses. The collection of the extra tubes will therefore be done at the same time as the routine collection, without any additional invasive procedure.
Key inclusion criteria (3 listed)
- Patients admitted to the Amiens-Picardie University Hospital and having benefited from medical biology examinations including the parameters of interest
- according to the usual management modalities and without additional sampling
- at the time of the test period
Key exclusion criteria (1 listed)
- Refusal to participate in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| drone transportadditional transport of samples at room temperature by drone (departure from the CHU Amiens-Picardie, 1 hour flight in the CHU Amiens-Picardie air perimeter, return to the CHU Amiens-Picardie) | Other | drone transportation |
Primary outcome
variation of ASAT concentration between both groups
Time frame: one day
variation of ALAT concentration between both groups
Time frame: one day
variation of BNP concentration between both groups
Time frame: one day
variation of LDH concentration between both groups
Time frame: one day
variation of Glucose concentration between both groups
Time frame: one day
variation of Troponin concentration between both groups
Time frame: one day
variation of Potassium concentration between both groups
Time frame: one day
variation of HIL concentration between both groups
Time frame: one day
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Oct 2025.
- Individual participant dataSharing planned: No
Related trials for Biological Samples
RecruitingObservational study
Registry of Ehlers-Danlos Syndrome
Ehlers-Danlos Syndrome
RecruitingObservational study
Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers
Healthy Volunteers
Not yet recruitingObservational study
Biological Analysis of MABs in NHL in a Translational Prospective Observational Study Within Italian Clinical Practice
B-Cell Non-Hodgkin Lymphoma (NHL)
RecruitingObservational study
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Malignant Neoplasm
Enrolling by invitationObservational study
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Solid Tumors, Hematologic Malignancy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Biological Samples, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 6 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
variation of ASAT concentration between both groups (time frame: one day). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2025.